In this episode we dive into the topic of breathing pattern disorder. Anna Spathis a Consultant working in Palliative Medicine is in conversation with Catherine Moffat - a specialist respiratory physiotherapist.

This episode features Dr Fiona Mosgrove, GP with special interest in respiratory medicine, in conversation with Professor Robin Taylor, consultant physician with NHS Lanarkshire. Robin has in-depth experience of difficult prognostic conversations with patients with progressive lung disease.

Spirometry is a component of the diagnosis and management of respiratory conditions in primary care and should ideally be performed via referral to a primary care network respiratory diagnostic service or community diagnostics centre (CDC) with expertise in the diagnosis of the most common respir

Respiratory disease and frailty should be considered jointly when caring for this vulnerable group of patients.

Dr Fiona Mosgrove (GP with special interest in respiratory medicine) is joined by Professor Mona Bafadhel (Director for King's Centre for Lung Health and Chair of Respiratory Medicine at King's College) and Christine Mwasuku (Research Nurse and First Year PhD candidate funded by Asthma+LungUK) to

PCRS believe that it is the responsibility of every healthcare professional to treat tobacco dependency systematically and effectively. PCRS advocate that people wishing to quit using tobacco should be offered the most effective but also the least harmful methods first to support a quit attempt.

PCRS recognises a need for improvement in the timely diagnosis of people living with chronic breathlessness and generally welcomes the NHS England diagnostic pathway support tool. PCRS has some concerns that a diagnostic algorithm can communicate an oversimplification of diagnosis.

Concerns about the environmental impact of the propellant gases used in pressurised metered dose inhalers (pMDIs) and the plastics used in all single-use inhaler devices have made them an important focus for efforts to reduce the environmental impact of the NHS.

In this webinar please join Hitasha Rupani to discuss the following topics: 

In 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved the use of a dual (Inhaled corticosteroid/ Formoterol) combination treatment to be used as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an a

The resource also details what we in primary care can do about homelessness including reducing the barriers to engaging with services, and using clear and empathetic communication.

The Primary Care Respiratory Society (PCRS) advocates a pragmatic approach to the pharmacological management of patients with chronic obstructive pulmonary disease (COPD) guided by the predominance of breathlessness and/or exacerbations and the presence or absence of comorbid asthma.

The report explored the link between inequality and lung disease and the primary conclusions were:

A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis. Fractional exhaled Nitric Oxide (FeNO) tests are simple, non-invasive tests to support the diagnosis of asthma.